PFM Health Sciences’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

PFM Health Sciences’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-100,000	Closed	-$12.7M	–	93
2022 Q2	$12.7M	Buy	+100,000	New	+$11.5M	0.48%	54

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

PFM Health Sciences's KRTX Position: Q1 2024 in Review

PFM Health Sciences sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 130,293 shares — an estimated $41.2M sold.

PFM Health Sciences first reported a position in KRTX in Q2 2019 and held it in 18 quarters. The position peaked at $45.4M in Q4 2019. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

PFM Health Sciences reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
PFM Health Sciences sold 130,293 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $41.2M.
PFM Health Sciences first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2019 and held it in 18 quarters.
PFM Health Sciences's Karuna Therapeutics, Inc. Common Stock position peaked at $45.4M in Q4 2019.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on PFM Health Sciences's 13F filing for Q1 2024, filed 14 May 2024.